Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosis.
Chen BY, Salas JR, Trias AO, Perez Rodriguez A, Tsang JE, Guemes M, Le TM, Galic Z, Shepard HM, Steinman L, Nathanson DA, Czernin J, Witte ON, Radu CG, Schultz KA, Clark PM.
Chen BY, et al. Among authors: trias ao.
Immunology. 2023 Jan;168(1):152-169. doi: 10.1111/imm.13569. Epub 2022 Sep 4.
Immunology. 2023.
PMID: 35986643
Free PMC article.